These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28270397)

  • 1. Multiple primary malignancies of laryngeal cancer, small cell lung cancer and squamous cell lung cancer in a patient: how to approach MPMs.
    Kim EK; Kim JY; Kim BM; Lim SN
    BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28270397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results of alternating chemoradiotherapy with early assessment for advanced laryngeal cancer: A multi-institutional phase II study.
    Nakata Y; Ijichi K; Hanai N; Nishikawa D; Suzuki H; Hirakawa H; Kodaira T; Fujimoto Y; Fujii T; Miyazaki T; Shimizu T; Hasegawa Y
    Auris Nasus Larynx; 2017 Feb; 44(1):104-110. PubMed ID: 27435048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment results and prognostic factors for advanced squamous cell carcinoma of the larynx treated with concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Arai Y; Yamashita Y; Shiono O; Hirama M; Sakuma Y; Ishitoya J; Hata M; Ogino I; Oridate N
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):837-43. PubMed ID: 23959463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy.
    Popovtzer A; Burnstein H; Stemmer S; Limon D; Hili O; Bachar G; Sopov V; Feinmesser R; Groshar D; Shvero J
    Head Neck; 2017 Feb; 39(2):227-233. PubMed ID: 27556178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.
    Mesía R; Garcia-Saenz JA; Lozano A; Pastor M; Grau JJ; Martínez-Trufero J; Lambeaz J; Martínez-Galán J; Mel JR; González B; Vázquez S; Mañós M; Taberna M; Cirauqui B; Del Barco E; Casado E; Rubió-Casadevall J; Rodríguez-Jaráiz A; Cruz JJ;
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):473-480. PubMed ID: 28011050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage pharyngolaryngectomy with total esophagectomy following definitive chemoradiotherapy.
    Niwa Y; Koike M; Fujimoto Y; Oya H; Iwata N; Nishio N; Hiramatsu M; Kanda M; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Nomoto S; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):598-602. PubMed ID: 26338205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous Laryngeal Squamous Cell Carcinoma and Intrahepatic Cholangiocarcinoma Present in an Obese Male with Poor Prognosis.
    Jiang P; Gu L; Zhou Y; Zhao Y; Lai J
    Anticancer Res; 2018 Sep; 38(9):5547-5550. PubMed ID: 30194215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laryngeal paraganglioma in an irradiated neck.
    Pham TA; De Freitas R; Young G; Safdar A
    J Laryngol Otol; 2012 Jul; 126(7):747-50. PubMed ID: 22643318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Study of Cetuximab, Carboplatin, and Radiation Therapy for Patients With Locally Advanced Head and Neck Squamous Cell Cancer Unfit for Cisplatin.
    Corry J; Bressel M; Fua T; Herschtal A; Solomon B; Porceddu SV; Wratten C; Rischin D
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):948-954. PubMed ID: 28483336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results and prognostic factors for advanced squamous cell carcinoma of the head and neck treated with salvage surgery after concurrent chemoradiotherapy.
    Taguchi T; Nishimura G; Takahashi M; Shiono O; Komatsu M; Sano D; Yabuki KI; Arai Y; Yamashita Y; Yamamoto K; Sakuma Y; Oridate N
    Int J Clin Oncol; 2016 Oct; 21(5):869-874. PubMed ID: 26908193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of synchronous triple cancer treated with multidisciplinary therapy - cancers in the middle part of the extrahepatic bile duct, the pancreas head, and the supraglottis].
    Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Kushihashi Y; Hasegawa A
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):2459-61. PubMed ID: 25731557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple primary cancers of the larynx, lung and thyroid presenting in one patient.
    Iqbal FR; Sani A; Gendeh BS; Aireen I
    Med J Malaysia; 2008 Dec; 63(5):417-8. PubMed ID: 19803306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
    Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
    Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New Combination Therapy to Improve the Functional Preservation Rate of the Larynx in Laryngeal, Oropharyngeal, and Hypopharyngeal Cancers].
    Furusaka T
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1141-7. PubMed ID: 26489542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined modality treatment of laryngeal squamous cell carcinoma.
    Devlin JG; Langer CJ
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple primary cancer of the lung and larynx].
    Trakhtenberg AKh; Ol'shanskiĭ VO; Frank GA; Kim IK; Anikin VA
    Vopr Onkol; 1986; 32(2):28-33. PubMed ID: 3008434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 2 study of docetaxel, cisplatin, and concurrent radiation for technically resectable stage III-IV squamous cell carcinoma of the head and neck.
    Inohara H; Takenaka Y; Yoshii T; Nakahara S; Yamamoto Y; Tomiyama Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Ogawa K
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):934-41. PubMed ID: 25832686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective study of treatment for curative synchronous double primary cancers of the head and neck and the esophagus.
    Okamoto T; Katada C; Komori S; Yamashita K; Miyamoto S; Kano K; Seino Y; Hosono H; Matsuba H; Moriya H; Sugawara M; Azuma M; Ishiyama H; Tanabe S; Hayakawa K; Koizumi W; Okamoto M; Yamashita T
    Auris Nasus Larynx; 2018 Oct; 45(5):1053-1060. PubMed ID: 29752155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.
    Cmelak AJ; Li S; Goldwasser MA; Murphy B; Cannon M; Pinto H; Rosenthal DI; Gillison M; Forastiere AA
    J Clin Oncol; 2007 Sep; 25(25):3971-7. PubMed ID: 17761982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.